Skip to main content

Notices of implemented actions

Implemented

  • 1.2: Definitions
  • 1.4.F: Updates to Candidate Data during 2020 COVID-19 Emergency (Repealed as of 07/27/2021; Reinstated as of 1/11/2022; Expired 4/11/2022)
  • 2.9: Required Deceased Donor Infectious Disease Testing
  • 2.11: Required Deceased Donor Information
  • 3.7.D: Applications for Modification of Kidney Waiting Time during 2020 COVID-19 Emergency
  • 18.1: Data Submission Requirements
  • 18.1.A: Retrospective Data Collection during COVID-19 Emergency
  • 18.2: Timely Collection of Data
  • 18.5.A: Reporting Requirements after Living Kidney Donation

18.5.B: Reporting Requirements after Living Liver Donation

The table below shows Implemented policy notices with detailed Item name, board action date, and effective implementation date

ItemActionEffective date
2025 Histocompatibility HLA Table Update (PDF)10/202511/13/2025

Update Data Collection for Lung Mortality Models (PDF)

  • Updates to Data System

12/2022

10/01/2025

Deceased Donor Support Therapy Data Collection (PDF)12/202310/01/2025
Enhancements to OPTN Donor Data and Matching System Clinical Data Collection (PDF)12/202210/01/2025
Improve Deceased Donor Evaluation for Endemic Diseases 06/202310/01/2025
Align OPTN KPD Blood Type Matching Policy and Establish Donor Re-Evaluation Requirements (PDF)06/202309/24/2025 
Amend Adult Heart Status 2 Mechanical Device Requirements (PDF)12/202309/17/2025
Monitor Ongoing eGFR Modification Policy Requirements (PDF)06/202509/10/2025
Clarify Requirements for Reporting a Potential Disease Transmission (PDF)06/202508/01/2025
Barriers Related to the Evaluation and Follow up of International Living Donors (PDF)06/202507/01/2025

Updates to National Liver Review Board Guidance and Further Alignment with LI-RADS (PDF)

  • Guidance Documents and NLRB Guidelines
06/2025

07/01/2025

Revisions to Human Immunodeficiency Virus (HIV) Policies to Align with Federal Regulatory Updates (PDF)06/202506/26/2025
Modify Guidance for Pediatric Heart Exception Requests to Address Temporary MCS Equipment Storage (PDF)06/202506/12/2025
Revise Conditions for Access to the OPTN Computer System (PDF)12/202403/27/2025
Update Criteria for Post-Transplant Graft Survival Metrics (PDF)11/202403/06/2025
Require Reporting of HLA Critical Discrepancies and Crossmatching Events to the OPTN (PDF)12/202403/05/2025
National Liver Review Board (NLRB) Updates Related to Transplant Oncology (PDF)6/202402/27/2025

Update Data Collection for Lung Mortality Models (PDF)

  • Updates to Waiting List & the Lung CAS Calculator on the OPTN site
  • Updates to Lung Labs APIs
12/2022

12/13/2023

2/19/2025

Modify Data Collection on Living VCA Donors (PDF)12/202012/11/2024
Update Human Leukocyte Antigen (HLA) Equivalency Tables, 2023 (PDF)12/202312/5/2024
Revised Bylaws and Management and Membership Policies (PDF)12/202412/2/2024
Optimizing Usage of Offer Filters (PDF)06/202311/14/2024
Refit Kidney Donor Profile Index without Race and Hepatitis C Virus (PDF)06/202410/31/2024

Update Liver Diagnosis Code Nomenclature & Treatment Options for HCC Exceptions (PDF)

  • HCC Treatment Options
  • Diagnosis Code Updates

03/2024

08/01/2024

10/10/2024

Standardize Six-Minute Walk for Lung Allocation 

06/04/2024

09/03/2024

Clarify Requirements for Pronouncement of Death (PDF)06/202407/25/2024

Modify Effect of Acceptance (PDF)

06/202407/25/2024

Standardize the Patient Safety Contact and Reduce Duplicate Reporting (PDF)

  • Patient Safety Contact
06/202407/25/2024
Enhance Transplant Program Performance Monitoring System, Phase 3 (PDF)12/20217/25/2024
Establish Code of Conduct and Whistleblower Protections (PDF)06/202407/01/2024
Modify Organ Offer Acceptance Limit (PDF)12/202305/29/2024
Remove CPRA 99-100% Form for Highly Sensitized Candidates (PDF)

12/2023

05/02/2024
Expedited Placement Variance (PDF)03/202404/02/2024
Proposal to Address the Relationship of the OPTN and OPTN Contractor Board (PDF)03/202403/30/2024
Establish Member System Access, Security Framework, and Incident Management and Reporting Requirements (PDF)06/202303/19/2024
Recognizing Seasonal and Geographically Endemic Infections in Organ Donors: Considerations during Deceased and Living Donor Evaluation (PDF)12/202301/10/2024
Require Reporting of Patient Safety Events (PDF)12/202301/10/2024
Update Guidance on Optimizing VCA Recovery (PDF)12/202301/10/2024

Establish Membership Requirements for Uterus Transplant Programs (PDF)

12/202112/5/2023

Modify Heart Policy for Intended Incompatible Blood Type (ABOi) Offers to Pediatric Candidates (PDF)

06/202311/30/2023

Establish Member System Access, Security Framework, and Incident Management and Reporting Requirements (PDF)

  • Readiness assessment and annual attestations
06/202311/20/2023
Update Multi-Organ Allocation for Continuous Distribution of Lungs (PDF)12/202209/28/2023
Establish Eligibility Criteria and Safety Net for Heart-Kidney and Lung-Kidney Allocation (PDF)06/202209/28/2023
Expand Required Simultaneous Liver-Kidney Allocation (PDF)06/202309/28/2023
Modify Lung Allocation by Blood Type (PDF)09/202309/27/2023
Apply Transplant Notification Requirements for VCA Program Inactivation (PDF)12/202209/14/2023
Data Collection to Evaluate Organ Logistics and Allocation (PDF)12/202109/14/2023
Report Primary Graft Dysfunction in Heart Transplant Recipients (PDF)12/202109/14/2023
Modifications to the Deceased Donor Registration (DDR) (PDF)06/202109/14/2023
Update Data Collection to Align with U.S Public Health Service Guideline, 2020 (PDF)12/202109/14/2023
Standardize Kidney Biopsy Reporting and Data Collection (PDF)06/202209/14/2023

Programming VCA Allocation in UNet (PDF)

12/202009/14/2023

Modify Graft Failure Definition for VCA (PDF)

06/202209/14/2023
Update to VCA Transplant Outcomes Data Collection (PDF)12/202009/14/2023

Align OPTN Policy to Support Changes to Race and Ethnicity Data Collection (PDF)

9/8/2023 Exec Comm Action09/14/2023

Establish Member System Access, Security Framework, and Incident Management and Reporting Requirements (PDF)

  • Require Reporting of Security Incidents
06/20238/1/2023

National Liver Review Board (NLRB) Guidance for Multivisceral Transplant Candidates (PDF)

06/2023 Board Action07/31/2023

Ongoing Review of National Liver Review Board (NLRB) Diagnoses (PDF)

06/2022 Board Action07/13/2023

Improving Liver Allocation: MELD, PELD, Status 1A and Status 1B (PDF)

06/2022 Board Action07/13/2023
Establish Continuous Distribution of Lungs (PDF)12/2021 Board Action03/09/2023
Revise Lung Review Board Guidelines, Guidance, and Policy for Continuous Distribution (PDF)12/2022 Board action03/09/2023

Update Multi-Organ Allocation for Continuous Distribution of Lungs (PDF)

  • 5.10.E: Other Multi-Organ Combinations
  • 6.6.F.i: Allocation of Heart-Lungs from Deceased Donors at Least 18 Years Old
  • 6.6.F.ii: Allocation of Heart-Lungs from Deceased Donors Less Than 18 Years Old
12/2022 Board action03/09/2023

Update Kidney Paired Donation Policy (PDF)

12/2022 Board action02/01/2023
Change Calculated Panel Reactive Antibody (CPRA) Calculation (PDF)6/2022 Board action1/26/2023
Continued Review of National Liver Review Board (NLRB) Guidance (PDF)12/2022 Board action1/05/2023
Modify Waiting Time for Candidates Affected by Race-Inclusive eGFR Calculations (PDF)12/2022 Board action1/05/2023
Transparency in Program Selection (PDF)12/2022 Board action1/05/2023
Amend Status Extension Requirements in Adult Heart Allocation Policy (PDF)12/2021 Board Action10/27/2022
Review of Liver and Intestine Variances in OPTN Policy (PDF)10/2022 Executive Committee action10/26/2022
Establish Minimum Kidney Donor Criteria to Require Biopsy (PDF)6/2022 Board action09/06/2022
Cross Organ Data Alignment (PDF)6/2022 Board action08/30/2022
Modify Data Submission Policies (PDF)12/2019 Board action08/30/2022
Update Human Leukocyte Antigen (HLA) Equivalency Tables (PDF)12/2021 Board action08/30/2022

Align OPTN Policy with US Public Health Service Guideline, 2020 (PDF)

  • Data collection for recipient HBV vaccination status
12/2020 Board action08/30/2022

Further Enhancements to the National Liver Review Board (PDF)

  • Policy 9.5.I.i: Initial Assessment and Requirements for HCC Exception Requests
12/2020 Board action08/30/2022

Review of National Liver Review Board (NLRB) Diagnoses and Update to Alcohol Associated Diagnoses (PDF)

  • Changes to Transplant Candidate Registration Form
    Changes to Transplant Recipient Registration Form

12/2021 Board Action

08/30/2022

Refine Lung Data Fields (PDF)

  • Data collection clarification for lung height and weight details
07/2021 Executive Committee action08/30/2022
Establish OPTN Requirement for Race-Neutral Estimated Glomerular Filtration Rate (eGFR) Calculations (PDF)6/2022 Board action7/27/2022

Modify Living Donor Exclusion Criteria (PDF)

  • 14.4.E: Living Donor Exclusion Criteria
6/2022 Board action7/26/2022

Ongoing Review of National Liver Review Board (NLRB) Diagnoses (PDF)

 Split implementation. Additional actions targeted for April 2023 implementation.

Guidance to Liver Transplant Programs and the National Liver Review Board for Adult MELD Exceptions for Hepatocellular Carcinoma (HCC)

Guidance to Liver Transplant Programs and the National Liver Review Board for Adult MELD Exceptions Review

6/2022 Board action7/26/2022

Modify Heart Policy to Address Patient Safety Following Device Recall

7/2022 Executive Committee Action; 12/2022 Board action7/14/2022

Enhance Transplant Program Performance Monitoring System, Phase 1 (July 2022) (PDF)

  • Inquiries related to post-transplant outcomes
6/2022 Board Action7/14/2022
Pediatric Candidate Pre-Transplant HIV, HBV, and HCV Testing (PDF)6/2022 Board Action7/1/2022
Calculate Median MELD at Transplant around the Donor Hospital and Update Sorting within Liver Allocation (PDF)06/2021 Board Action06/28/2022
Enhance Transplant Program Performance Monitoring System (PDF)12/2021 Board ActionCohorts for pre- transplant metrics begin 1/1/2022

Clarify Multi-Organ Allocation Policy (PDF)

06/2021 Board action02/10/2022
Guidance for Data Collection Regarding Classification of Citizenship Status (PDF)12/2021 Board Action02/01/2022
Ethical Considerations of Continuous Distribution in Organ Allocation (PDF)12/2021 Board Action02/01/2022

Review of National Liver Review Board (NLRB) Diagnoses and Update to Alcohol Associated Diagnoses (PDF)

  • 9.5.I.i: Initial Assessment and Requirements for HCC Exception Requests
  • 9.5.I.vii: Extensions of HCC Exceptions
  • Guidance to Liver Transplant Programs and the National Liver Review Board for Adult MELD Exceptions for Hepatocellular Carcinoma (HCC)
  • Guidance to Liver Transplant Programs and the National Liver Review Board for Adult MELD Exceptions Review

12/2021 Board Action02/01/2022
Implemented policy items in 2021  
Extending Hawaii Puerto Rico Closed Blood Type Variance (PDF)12/2020 Board action

12/6/2021

Extend HIV Organ Policy Equity (HOPE) Act Variance (PDF)12/2020 Board action

12/6/2021

Lower Respiratory SARS-CoV-2 Testing for Lung Donors

4/26/2021 Executive Committee Action; 12/2021 Board action

5/27/2021

Update to Refusal Codes (PDF)6/2021 Board action12/2/2021

Further Enhancements to the NLRB

  • Policy 9.5.G: Requirements for Portopulmonary Hypertension MELD or PELD Score Exceptions
  • National Liver Review Board Operational Guidelines
  • Guidance to Liver Transplant Programs and the National Liver Review Board for Adult MELD Exception Review
12/2020 Board action10/07/2021

Updating National Liver Review Board Guidance and Policy Clarification (PDF)

  • Policy 9.5.A: Requirements for Cholangiocarcinoma (CCA) MELD or PELD Score Exceptions
06/2021 Board action

10/07/2021

Refine Lung Data Fields (PDF)

07/2021 Executive Committee Action

09/30/2021

Updated Cohort for Calculation of the LAS (PDF)

12/2020 Board action

09/30/2021

Require Notification of Critical Human Leukocyte Antigen (HLA) Typing Changes (PDF)

06/2021 Board action

09/01/2021

Modify Living Donor Policy to Include Living VCA Donors (PDF)

06/2021 Board action

09/01/2021

Updating National Liver Review Board Guidance and Policy Clarification (PDF)

  • Guidance to Liver Transplant Programs and the National Liver Review Board for Pediatric MELD or PELD Exception Review
  • Guidance to Liver Transplant Programs and the National Liver Review Board for Adult MELD Exception Review
06/2021 Board action

07/15/2021

Human Leukocyte Antigen (HLA) Equivalency Tables Update 2020 (PDF)

06/2020 Board action

06/17/2021

National Heart Review Board for Pediatrics (PDF)

06/2020 Board action

06/15/2021

Clarification of Policies and Bylaws Specific to Vascularized Composite Allografts (PDF)

06/2021 Board action

06/14/2021

Combined Policy Notice for VCA Membership Requirements (2020) (PDF)

 

VCA - List Covered Body Parts - 1 of 2 (PDF)

  • Policy 1.2: Definitions
  • Bylaws Appendix D: Membership Requirements for Transplant Hospitals and Transplant Programs; Appendix J: Membership Requirements for Vascularized Composite Allograft (VCA) Transplant Programs; and Appendix M: Definitions

 

Align VCA program membership requirements with other programs (PDF)

 

Membership Requirements for VCA Transplant Programs (PDF)

06/2015, 06/2016, 06/2018 Board action

06/14/2021

Align OPTN Policy with US PHS Guideline 2020 (PDF)

  • Policy 14.3: Informed Consent Requirements
  • Policy 14.8.B: Living Donor Specimen Collection and Storage

12/2020 Board action

06/01/2021

Expedited Liver Placement (PDF)

12/2019 Board action03/25/2021

Pancreas Removal of DSA (PDF)

12/2019 Board action03/15/2021

Kidney Removal of DSA (PDF)

12/2019 Board action03/15/2021

Addressing Medically Urgent Candidates in New Kidney Allocation Policy (PDF)

06/2020 Board action03/15/2021

Distribution of Kidneys and Pancreata from Alaska (PDF)

06/2020 Board action03/15/2021

Modifications to Released Kidney and Pancreas Allocation (PDF)

06/2020 Board action03/15/2021

Guidance and Policy Addressing Adult Heart Allocation (PDF)

  • Policy 6.1.A.ii: Non-dischargeable, surgically implanted, non-endovascular biventricular support device: Effective March 4, 2021
  • Policy 6.1.C.vi: Mechanical Circulatory Support Devise (MCSD) with Device Infection: Effective March 4, 2021
  • Policy 6.1.D.ii: Inotropes without Hemodynamic Monitoring: Effective March 4, 2021
  • Guidance for Adult Heart Exceptions for
    Status 2 Candidates Experiencing Cardiogenic Shock: Effective February 9, 2021
12/2020 Board action02/09/2021, 03/04/2021

Align OPTN Policy with US PHS Guideline 2020 (PDF)

Split implementation. Additional actions targeted for June 2021 implementation.

  • 1.2: Definitions
  • 2.2: OPO Responsibilities
  • 2.4: Deceased Donor Medical and Behavioral History
  • 2.5: Hemodilution Assessment
  • 2.7.A: Exceptions to HIV Screening Requirement
  • 2.9: Required Deceased Donor Infectious Disease Testing
  • 13.11: Receiving and Accepting KPD Match Offers
  • 14.1.A: Living Donor Psychosocial Evaluation Requirements
  • 14.4.A: Living Donor Medical Evaluation Requirements
  • 14.9.B: Psychosocial and Medical Evaluation Requirements for Domino and Non-Domino Therapeutic Donors
  • 15.2: Potential Candidate Screening Requirements
  • 15.3.B: Donors with  Risk Identified Pre-Transplant
  • 15.3.C: Recipients of Organs from Donors with Increased Risk of Disease Transmission
  • 16.3.D: internal labeling of Extra Vessels
12/2020 Board action03/2021

Guidance Addressing the Use of Pediatric Heart Exceptions (PDF)

12/2020 Board action02/09/2021
Further Enhancements to the National Liver Review Board (PDF)
  • Split implementation. Additional actions targeted for June 2021 implementation.
  • Guidance to Liver Transplant Programs and the National Liver Review Board for Adult MELD Exception Review
12/2020 Board action02/09/2021
Implemented policy items in 2020  
Establish Pediatric Training and Experience (PDF)12/2015 Board actions12/07/2020
Revise Pediatric Emergency Membership Exception Pathway (PDF)12/2017 Board action12/07/2020
Incorporating COVID-19 Related Organ Failure In Candidate Listings (PDF)10/2020 Board action10/28/2020
Enhancements to the National Liver Review Board (PDF)
  • Policies 9.4.A: MELD or PELD Score Exception Requests and 9.4.D: Calculation of Median MELD or PELD at Transplant: Effective August 4, 2020
  • Operational Guidelines: Effective August 4, 2020
  • Operational Guidance: Effective August 4, 2020
  • Policies 9.4.C: MELD or PELD Score Exception Extensions and 9.5.I.vii: Extensions of HCC Exceptions: Effective September 10, 2020
06/2020 Board action08/04/2020, 09/10/2020
Guidance and Policy Modifications Addressing Blood Type Determination (PDF)
  • Guidance: Effective June 8, 2020
  • Policy: Effective September 1, 2020
06/2020 Board action06/08/2020,09/01/2020
Modify the Conflicts of Interests Bylaws (PDF)06/2020 Board action07/01/2020
Creation of OPTN Heart and Lung Committees (PDF)03/2020 Board action07/01/2020
Modify Lung TRF to Improve Post Transplant Lung Function Data06/2018 Board action06/30/2020
Eliminate the Use of Regions in VCA Distribution (PDF)06/2019 Board action06/18/2020
Modify HOPE Act Variance to Include Other Organs (PDF)06/2019 Board action05/21/2020
COVID-19 Emergency Policy Package (PDF)04/2020 Executive Committee action04/03/2020
Clarifications on Reporting Maintenance Dialysis (PDF)06/2019 Board action04/01/2020
Updates to Candidate Data During 2020 COVID-19 Emergency (PDF)03/2020 Executive Committee action03/17/2020
Variances Removal Policy Notice (PDF)12/2019 Board action03/01/2020
Clarification of Pre-Existing Liver Disease (PDF)12/2019 Board action03/01/2020
Addressing HLA Typing Errors12/2018 Board action02/27/2020
Access for Urgent Liver Candidates in Hawaii & Puerto Rico (PDF)01/2020 Executive Committee action02/18/2020
Liver and Intestine Distribution Using Distance from Donor Hospital (PDF)12/2018 Board action02/04/2020
Reduce Reporting Burdens and Clarify Policies on Extra Vessels (PDF)
  • Table 16.1: Required information on internal labels for extra vessels, number 7 (donor infectious disease results)
06/2018 Board action01/29/2020
Update Transplant Hospital Definition (PDF)12/2016 Board action01/13/2020
Eliminate the Use of DSAs in Thoracic Organ Distribution (PDF)06/2019 Board action01/09/2020
Implemented policy items in 2019  
Adding DR Antigens and Equivalences (PDF)12/2019 Board Action12/04/2019
Hope Act Policy and Mini Brief (PDF)12/2019 Board action12/03/2019
Modify Appointment Process for the Histocompatibility Vice Chair (PDF)12/2019 Board Action12/03/2019
Aligning Units of Distribution in Closed Variance for Split Liver Transplantation (PDF)12/2019 Board Action12/03/2019
Split Liver Variance (PDF)06/2019 Board action12/03/2019
Revising Priority Points in Kidney Paired Donation Program (PDF)12/2015 Board action;
10/2019 Executive Committee action		10/24/2019
Improving Dual Kidney Allocation12/2017 Board action9/2019
Improving en Bloc Kidney Allocation12/2017 Board action9/2019
Changes to Waiting Time Criteria for Kidney-Pancreas Candidates (PDF)06/2018 Board action7/11/2019
Guidance on Effective Practices in Organ Distribution06/2019 Board action6/10/2019
Ethical Implications of Multi-Organ Transplants White Paper06/2019 Board action6/10/2019
Revised National Liver Review Board Policies (PDF)12/2018 Board action5/14/2019
National Liver Review Board06/2017 Board action5/14/2019
Histocompatibility Bylaws Rewrite: General Supervisor (PDF)06/2015 Board action3/1/2018
Pancreas Program Functional Inactivity (PDF)12/2018 Board action4/8/2019
Addressing HLA Typing Errors (PDF)
  • Policy 2.2 (OPO responsibilities)
  • Bylaws C.2.D (OPO affiliation)
12/2018 Board action3/1/2019
Amend CPRA Calculator (PDF)01/2019 Executive Committee action1/17/2019
Implemented policy items in 2018  
Change to Hospital-Based OPO Voting Privileges12/2018 Board action12/4/2018
Frameworks for Organ Distribution12/2018 Board action12/4/2018
Pediatric Transition and Transfer Guidance12/2018 Board action12/3/2018
Intestine Membership Bylaws Requirements06/2015 Board action11/20/2018
Modify Adult Heart Allocation12/2016 Board action10/18/2018
Clarification of Adult Heart Allocation08/2017 Executive Committee action10/18/2018
Review Board Guidance on HCM and RCM Exceptions06/2018 Board action10/18/2018
Modifications to the Distribution of Deceased Donor Lungs06/2018 Board action10/18/2018 (Policy 6.6.F)
06/12/2018 (Policies 1.2, 10.2.A, 10.4)
Clarify Informed Consent Policies for Transmittable Diseases06/2018 Board action09/01/2018
Reduce Reporting Burdens and Clarify Policies on Extra Vessels (PDF)06/2018 Board action09/01/2018 (except table 16.1)
VCA - List Covered Body Parts (2 0f 2) (PDF)
  • Bylaws Appendix J: Membership Requirements for Vascularized Composite Allograft (VCA) Transplant Programs: Effective September 1, 2018
  • Policy 1.2: Definitions: Target implementation date: December 2021
  • Bylaws Appendix D: Membership Requirements for Transplant Hospitals and Transplant Programs; Appendix J: Membership Requirements for Vascularized Composite Allograft (VCA) Transplant Programs; and Appendix M: Definitions: Target implementation date: December 2021
06/2016 Board action09/01/2018
Improving the Efficiency of Organ Allocation (PDF)12/2017 Board action03/01/2018 (Policies 2.2, 2.11 and 2.12)
05/02/2018 (Policies 1.2 and 5.6.B)
06/12/2018 (Policies 2.11.A and 2.11.D)
06/13/2018 (Policy 5.6.C)
Revising OPTN Bylaws Appendix L (PDF)06/2018 Board action06/12/2018
Retrospective Review of Clerical Policy Changes (PDF)06/2018 Executive Committee action06/12/2018
Approved Transplant Fellowship Training Programs Bylaws (PDF)12/2017 Board action03/01/2018
Definition of Pancreas Graft Failure (PDF)06/2015 Board action2/28/2018
Modification to HCC Extension Criteria (PDF) 2/5/2018
Implemented policy items in 2017  
HCC Auto Approval Criteria Changes12/2016 Board action
12/2017 Executive Committee action		12/12/2017
Lung Allocation Policy Modification (PDF)11/2017 Executive Committee action11/24/2017
Standardize Organ Coding and Tracking System2/2017 Executive Committee action11/01/2017
Improve the Categorization of Living Donor Events (PDF)9/2017 executive committee action10/18/2017
Add DQA-1 Equivalences Table6/2016 Board action
6/2017 Executive Committee action		09/12/2017
Update HLA Equivalency Tables12/2015 Board action
4/2017 Executive Committee action		09/12/2017
Personnel Procurement Requirements12/2015 Board action09/01/2017
Foreign Equivalent in Bylaws12/2015 Board action09/01/2017
Bylaws Rewrite06/2017 Board action09/01/2017
Primary Kidney Transplant Physician Update (PDF)12/2016 Board action09/01/2017
Clarification to Apply Kidney Minimum Acceptance Criteria to Highly Sensitized Candidates (PDF)07/2017 Executive Committee action09/01/2017
Simultaneous Liver-Kidney Allocation06/2016 Board action08/10/2017
Kidney: KAS Clarifications (part)06/2016 Board action06/29/2017
Retrospective Review of Clerical Changes to Policies (PDF)06/2017 Executive committee action06/29/2017
Informed Consent Changes - Potential Living Donors12/2016 Board action06/01/2017
Improving Post-Transplant Communication (part)06/2016 Board action; Required toxoplasmosis testing of all donors04/06/2017
Pediatric Lung Allocation Changes (PDF)12/2015 Board action03/30/2017
All Other KPD Guidelines to Policy (part)06/2015 Board action03/30/2017
Post-Implementation ABO Policy Changes (PDF)12/2016 Board action03/01/2017
Primary Transplant Surgeon Changes12/2016 Board action03/01/2017
Primary Transplant Physician Subspecialty Changes12/2016 Board action03/01/2017
Remove Donor Location from Required Procurement Log (PDF)12/2016 Board action03/01/2017
Changes to Imminent and Eligible Definitions (PDF)12/2016 Board action01/01/2017
Implemented policy items in 2016  
Retrospective Review of Clerical Changes to Policies (PDF)12/2016 Executive committee action11/10/2016
Registration Fee (PDF)06/2016 Board action10/01/2016
DTAC Policy Clarification (PDF)06/2016 Executive Committee action09/01/2016
OSC Policy Clarification (PDF)08/2016 Executive Committee action09/01/2016
HOPE Act (PDF)06/2016 Board action09/01/2016
Improving Post-Transplant Communication (part)06/2016 Board action09/01/2016
Kidney: KAS Clarifications (part)06/2016 Board action09/01/2016
Regional Councillor Vacancy (PDF)06/2016 Board action09/01/2017
Living Donor Candidate Registration (PDF)04/2016 Executive Committee action04/14/2016
Retrospective Review of Clerical Changes to Policies (PDF)12/2016 Executive committee action4/14/2016
Implemented policy items in 2015  
KPD Informed Consent (PDF)06/2015 Board action12/01/2015